BioSpace News Archive

Biotech Bay

Arcus Biosciences Announces New Employment Inducement Grants - June 09, 2021

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 115,800 shares of the Company’s common stock at an exercise price per share of $24.76, which was the closing price on June 8, 2021.

June 9, 2021
·
2 min read
BioForest

Omeros to Present at the BofA 2021 Napa BioPharma Virtual Conference

Omeros Corporation (Nasdaq: OMER), today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the BofA 2021 Napa BioPharma Virtual Conference next week.

June 9, 2021
·
2 min read
Deals

Aclaris Announces Pricing of Public Offering of Common Stock - June 09, 2021

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced the pricing of its underwritten public offering of 7,042,254 shares of its common stock at a price to the public of $17.75 per share.

June 9, 2021
·
3 min read
Deals

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome

Nautilus Biotechnology, Inc. announced the completion of its business combination with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors.

June 9, 2021
·
7 min read
Business

Health and Human Services Expert Mary L. Smith Joins PTC Therapeutics’ Board of Directors

Ms. Smith has previously served as the Principal Deputy Director and CEO equivalent at the Indian Health Service, a $6 billion division of the U.S. Department of Health and Human Services and system of hospitals providing healthcare to more than two million Native Americans in the United States.

June 9, 2021
·
4 min read
Pharm Country

Eisai to Present Latest DAYVIGO® (lemborexant) CIV Data at 35th Annual Virtual SLEEP 2021 Meeting

Eisai Inc. announced today new presentations featuring the latest data about the company’s insomnia medication DAYVIGO will be presented at the 35th annual SLEEP 2021 meeting of the Associated Professional Sleep Societies, LLC (APSS).

June 9, 2021
·
9 min read
Genetown

Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in June

Gamida Cell Ltd. today announced that company management will present its corporate highlights at the following investor conferences in June.

June 9, 2021
·
2 min read
Bold Therapeutics Receives Additional Funding to Support Development of BOLD-100 as a Novel Antiviral

Bold Therapeutics is pleased to announce that it is receiving advisory services and additional research and development funding of up to CAD$965,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

June 9, 2021
·
3 min read
Business

Heart & Vascular Center at Valley View Offers Open Heart Surgery and New Cardiothoracic Procedures, Under the Leadership of Cardiothoracic Surgeon Stephen Jones, MD

The Heart & Vascular Center at Valley View is pleased to introduce new services to continue to provide patients with world-class, convenient and compassionate care on the Western Slope.

June 9, 2021
·
4 min read
FDA

Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)

Arena Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to etrasimod.

June 9, 2021
·
5 min read